NBTY to Web Cast Presentation at Canaccord Adams Global Growth Conference; Announces Preliminary Unaudited Net Sales Results for

Share Name	Share Symbol	Market	Type
Nabriva Therapeutics Plc	TG:NTY	Tradegate	Ordinary Share

Share Name

Share Symbol

Market

Type

Nabriva Therapeutics Plc

TG:NTY

Tradegate

Ordinary Share

Price Change

% Change

Share Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

0.00

NBTY to Web Cast Presentation at Canaccord Adams Global Growth Conference; Announces Preliminary Unaudited Net Sales Results for

10/08/2009 12:00pm

PR Newswire (US)

Nabriva Therapeutics (TG:NTY)
Historical Stock Chart

From May 2019 to May 2024

Click Here for more Nabriva Therapeutics Charts.

RONKONKOMA, N.Y., Aug. 10 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE:NTY) (http://www.nbty.com/), a leading global manufacturer and marketer of nutritional supplements, today announced that it will web cast the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the Canaccord Adams Global Growth Conference in Boston on Thursday, August 13, 2009. The presentation is scheduled to be web cast live on the Company Web site, http://www.nbty.com/, on Thursday, August 13 at 1:00PM Eastern Time. NBTY's preliminary unaudited net sales results for July 2009 by segment are as follows: NET SALES (Preliminary and Unaudited) FOR THE MONTH OF JULY ($In Millions) 2009 2008 % Change Wholesale / US Nutrition $125 $105 19% North American Retail $17 $17 -2% European Retail $55 $47 17% Direct Response / E-Commerce $19 $19 1% ------------------------------- Total $215 $188 15% =============================== Leiner Health Products, which was acquired on July 14, 2008, has been fully integrated into Wholesale / US Nutrition net sales. North American Retail same store sales decreased 3% for the one month period. European Retail net sales for July 2009 include $9 million from Julian Graves, which NBTY acquired on September 16, 2008. Without Julian Graves sales, European Retail net sales decreased 3%. In local currency (British Pound Sterling), excluding Julian Graves sales, European Retail net sales increased 19%. ABOUT NBTY NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company's Nature's Bounty (http://www.naturesbounty.com/), Vitamin World (http://www.vitaminworld.com/), Puritan's Pride (http://www.puritan.com/), Holland & Barrett (http://www.hollandandbarrett.com/), Rexall (http://www.rexall.com/), Sundown (http://www.sundownnutrition.com/), MET-Rx (http://www.metrx.com/), Worldwide Sport Nutrition (http://www.sportnutrition.com/), American Health (http://www.americanhealthus.com/), GNC (UK) (http://www.gnc.co.uk/), DeTuinen (http://www.detuinen.nl/), LeNaturiste(TM) (http://www.lenaturiste.com/), SISU (http://www.sisu.com/), Solgar (http://www.solgar.com/), Good 'n' Natural (http://www.goodnnatural.com/), Home Health(TM) (http://www.homehealthus.com/), Julian Graves, and Ester-C (http://www.ester-c.com/) brands. NBTY routinely posts information that may be important to investors on its web site. Contact: Harvey Kamil Carl Hymans NBTY, Inc. G.S. Schwartz & Co. President & Chief Financial Officer 212-725-4500 631-200-2020 DATASOURCE: NBTY, Inc. CONTACT: Harvey Kamil, President & Chief Financial Officer, NBTY, Inc., +1-631-200-2020; or Carl Hymans, G.S. Schwartz & Co., +1-212-725-4500, Web Site: http://www.nbty.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

NTY Nabriva Therapeutics Plc